MLchartDataset catalogue

autologous dinitrophenyl-modified ovarian cancer vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011609

A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.

Table 1. Record
IdentifierMLC-T-ONC-011609
FieldOncology and biomedicine
Synonymsautologous DNP-modified ovarian cancer vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011609",
  "term": "autologous dinitrophenyl-modified ovarian cancer vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.",
  "synonyms": [
    "autologous DNP-modified ovarian cancer vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine/"
}

Record 2,943 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.